Liarozole inhibits human epidermal retinoic acid 4-hydroxylase activity and differentially augments human skin responses to retinoic acid and retinol in vivo. - Kang,S.; Duell,EA.; Kim,KJ.; Voorhees,JJ. (J Invest Dermatol, 1996)